Home Compare BSX
Peer Analysis

Boston Scientific Corporation — Peer Companies & Stock Comparisons

Boston Scientific Corporation's functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.

Compare BSX with peers
Comparison BSX peer score
Boston Scientific Corporation vs Neurocrine Biosciences, Inc.
56 Compare →
Boston Scientific Corporation vs Insulet Corporation
50 Compare →
Boston Scientific Corporation vs GALD.SW
50 Compare →
Boston Scientific Corporation vs Amer Sports, Inc.
41 Compare →
Boston Scientific Corporation vs DexCom, Inc.
69 Compare →
Boston Scientific Corporation vs Stryker Corporation
61 Compare →
Boston Scientific Corporation vs Safran SA
68 Compare →
Boston Scientific Corporation vs MercadoLibre, Inc.
49 Compare →
Boston Scientific Corporation vs ServiceNow, Inc.
45 Compare →
Boston Scientific Corporation vs HEICO Corporation
57 Compare →
Boston Scientific Corporation vs nVent Electric plc
42 Compare →

Full BSX analysis in AssetNext

View the complete Boston Scientific Corporation report including all peer dimensions.

Open in AssetNext →

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.